Workflow
novocure(NVCR) - 2023 Q4 - Earnings Call Presentation

q4 2023 selected financial highlights patientforward® @ 2024 Novocure GmbH 9 novocure® Optune Lua® and Optune Gio® indications for use and important safety information novocure® | --- | --- | --- | --- | |----------------------------------------------|-------|-------|-------| | | | | | | | | | | | | | | | | Novocure | | | | | Q4 2023 Earnings Thursday, February 22, 2024 | | | | forward-looking statements ln addition to historical facts or statements of current condition, this presentation may contain forwar ...